ERBB2 and breast cancer: The discovery of HER2 in the 1980s allowed the development of therapeutical strategies that have dramatically changed the natural history of HER2+ breast cancer, with significantly improved outcomes (Coussens et al., 1985; Slamon and Pegram 2001).